文献速递消化道肿瘤与早癌消化内镜

锯齿状息肉病综合征患者结直肠癌风险:系统评价与Meta分析

Risk of Colorectal Cancer in Serrated Polyposis Syndrome: A Systematic Review and Meta-analysis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-06-02

SPS患者总体CRC风险为19.9%(95%CI 15.3%-24.5%),诊断时风险为14.7%(95%CI 11.4%-18.8%),监测期间风险为2.8%(95%CI 1.8%-4.4%)或每1000人年7例。结论提示SPS患者CRC风险升高,诊断时最高,监测期间持续存在,支持早期识别和加强监测。

要点

  • SPS患者总体CRC风险为19.9%,诊断时风险最高达14.7%。
  • 监测期间CRC风险为2.8%或每1000人年7例,持续存在。
  • SPS诊断前CRC病史发生率为7.0%,WHO亚型间无显著差异。

核心结论

  • SPS患者结直肠癌风险显著升高,诊断时最高,监测期间持续存在,支持早期识别和加强监测。

主要发现

  • SPS患者总体CRC风险为19.9%(95%CI 15.3%-24.5%)。
  • 诊断时CRC风险为14.7%(95%CI 11.4%-18.8%)。
  • 监测期间CRC风险为2.8%(95%CI 1.8%-4.4%),或每1000人年7例。
  • SPS诊断前CRC病史发生率为7.0%(95%CI 4.6%-11.7%)。
  • 亚组分析未显示世界卫生组织(WHO)亚型间CRC风险有显著差异。

临床怎么用

  • 应早期识别SPS以改变CRC风险,监测期间需遵循指南推荐的加强监测方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Serrated polyposis syndrome (SPS) is characterized by development of numerous serrated lesions throughout the colorectum and increased risk of colorectal cancer (CRC). However, SPS has been an underrecognized CRC predisposition syndrome, and the true risk of CRC in SPS, both overall and in surveillance, is not known. The aim of this systematic review and meta-analysis is to describe the risk of CRC in patients with SPS. METHODS: Electronic databases were searched on March 25, 2021, for studies describing CRC risk in SPS. Random-effects meta-analysis was performed to assess pooled risk of CRC among SPS patients. Primary outcomes were risk of CRC at time of SPS diagnosis and during surveillance following diagnosis of SPS. Secondary outcomes included risk of CRC prior to diagnosis of SPS and effect of World Health Organization subtype on CRC risk. RESULTS: Thirty-six studies including 2788 patients with SPS were included in the analysis. Overall risk of CRC in SPS was 19.9% (95% confidence interval [CI], 15.3%-24.5%). CRC risk at the time of diagnosis was 14.7% (95% CI, 11.4%-18.8%), while risk during surveillance was 2.8% (95% CI, 1.8%-4.4%), or 7 cases per 1000 person-years. SPS patients also had a high incidence of history of CRC prior to SPS diagnosis (7.0%; 95% CI, 4.6%-11.7). Subgroup analysis did not reveal any significant differences based on World Health Organization subtype. CONCLUSIONS: Our meta-analysis demonstrated that patients with SPS have an elevated risk of CRC, which is highest at the time of diagnosis and suggests the importance of early SPS recognition and screening to modify CRC risk. The persistently elevated CRC risk during surveillance supports current guidelines recommending heightened surveillance protocols.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Muller C, Yamada A, Ikegami S, et al. Risk of Colorectal Cancer in Serrated Polyposis Syndrome: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 2021. PMID: 34089849. doi:10.1016/j.cgh.2021.05.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。